|
EPB41 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.81348294556483E-12 |
| Normal-vs-Stage2 |
2.187000E-04 |
| Normal-vs-Stage3 |
9.01679997333815E-09 |
| Normal-vs-Stage4 |
9.29160004492502E-09 |
| Stage1-vs-Stage2 |
1.341570E-01 |
| Stage1-vs-Stage3 |
7.963200E-03 |
| Stage1-vs-Stage4 |
5.601800E-03 |
| Stage2-vs-Stage3 |
6.661800E-01 |
| Stage2-vs-Stage4 |
5.938600E-01 |
| Stage3-vs-Stage4 |
9.307000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.356420E-03 |
| Normal-vs-Asian |
1.112490E-02 |
| Caucasian-vs-AfricanAmerican |
7.418500E-02 |
| Caucasian-vs-Asian |
9.603200E-01 |
| AfricanAmerican-vs-Asian |
4.852400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
6.08046946126706E-12 |
| Male-vs-Female |
9.087000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.042160E-01 |
| Normal-vs-Age(41-60Yrs) |
5.6621374255883E-15 |
| Normal-vs-Age(61-80Yrs) |
1.0769163338864E-14 |
| Normal-vs-Age(81-100Yrs) |
4.921700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.407600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.975400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.609200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.017000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.523600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.121400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.556610E-01 |
| Normal-vs-Grade 2 |
2.19789741962018E-11 |
| Normal-vs-Grade 3 |
3.77475828372553E-14 |
| Normal-vs-Grade 4 |
2.80980000044728E-07 |
| Grade 1-vs-Grade 2 |
5.652400E-01 |
| Grade 1-vs-Grade 3 |
3.197800E-01 |
| Grade 1-vs-Grade 4 |
5.482400E-02 |
| Grade 2-vs-Grade 3 |
1.870820E-01 |
| Grade 2-vs-Grade 4 |
2.461700E-02 |
| Grade 3-vs-Grade 4 |
1.325960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.99790192670457E-11 |
| Normal-vs-ccB subtype |
1.62749813625851E-11 |
| ccA subtype-vs-ccB subtype |
8.059500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.6256774532385E-13 |
| Normal-vs-N1 |
5.002800E-03 |
| N0-vs-N1 |
2.321000E-01 |
|
|
